AIM
LCTX icon

Athena Investment Management’s Lineage Cell Therapeutics LCTX Stock Holding History

Athena Investment Management’s Portfolio LCTX Stock Details LCTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-35,556
Closed -$9K – 137
2022
Q3 		$9K Hold
35,556
– – 0.01% 128
2022
Q2 		$18K Hold
35,556
– – 0.01% 129
2022
Q1 		$70K Buy
+35,556
New +$70K 0.05% 119